Literature DB >> 2869408

Resistance to the anti-anxiety effect of buspirone in patients with a history of benzodiazepine use.

E Schweizer, K Rickels, I Lucki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2869408     DOI： 10.1056/NEJM198603133141121

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI-988.

Authors:  L Singh; M J Field; C A Vass; J Hughes; G N Woodruff
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

Review 2.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

3.  Evaluation of the dependence potential of the selective 5-H1A agonist ipsapirone in rats and of its effects on benzodiazepine withdrawal.

Authors:  A J Goudie; M J Leathley
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 4.  Generalised anxiety disorder in elderly patients : epidemiology, diagnosis and treatment options.

Authors:  Alastair J Flint
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1,4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 1. Acute and in vitro effects.

Authors:  M B Assié; P Chopin; A Stenger; C Palmier; M Briley
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 6.  Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supporting neurochemical and behavioural evidence.

Authors:  N Andrews; S E File
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 7.  Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic.

Authors:  K L Goa; A Ward
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

Review 8.  Pharmacotherapy for anxiety and comorbid alcohol use disorders.

Authors:  Jonathan C Ipser; Don Wilson; Taiwo O Akindipe; Carli Sager; Dan J Stein
Journal:  Cochrane Database Syst Rev       Date:  2015-01-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.